Febrile urinary tract infection (UTI) is currently considered the most frequent cause of serious bacterial illness in children in the first 2 years of life. UTI in paediatrics can irreversibly damage the renal parenchyma and lead to chronic renal insufficiency and related problems. To avoid this risk, an early effective antibiotic treatment is essential. Moreover, prompt treatment is mandatory to improve the clinical condition of the patient, prevent bacteraemia, and avoid the risk of bacterial localization in other body sites. However, antibiotic resistance for UTI-related bacterial pathogens continuously increases, making recommendations rapidly outdated and the definition of the best empiric antibiotic therapy more difficult. Variation in pathogen susceptibility to antibiotics is essential for the choice of an effective therapy. Moreover, proper identification of cases at increased risk of difficult-to-treat UTIs can reduce the risk of ineffective therapy. In this review, the problem of emerging antibiotic resistance among pathogens associated with the development of paediatric febrile UTIs and the best potential solutions to ensure the most effective therapy are discussed. Literature analysis showed that the emergence of antibiotic resistance is an unavoidable phenomenon closely correlated with the use of antibiotics themselves. To limit the emergence of resistance, every effort to reduce and rationalise antibiotic consumption must be made. An increased use of antibiotic stewardship can be greatly effective in this regard.

Antibiotic Resistance in Paediatric Febrile Urinary Tract Infections / Esposito, S.; Biasucci, G.; Pasini, A.; Predieri, B.; Vergine, G.; Crisafi, A.; Malaventura, C.; Casadio, L.; Sella, M.; Pierantoni, L.; Gatti, C.; Paglialonga, L.; Sodini, C.; La Scola, C.; Bernardi, L.; Autore, G.; Canto, G. D.; Argentiero, A.; Cantatore, S.; Ceccoli, M.; De Fanti, A.; Suppiej, A.; Lanari, M.; Principi, N.; Pession, A.; Iughetti, L.. - In: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. - ISSN 2213-7173. - 29:(2022), pp. 499-506. [10.1016/j.jgar.2021.11.003]

Antibiotic Resistance in Paediatric Febrile Urinary Tract Infections

Biasucci G.;Predieri B.;Ceccoli M.;Iughetti L.
2022

Abstract

Febrile urinary tract infection (UTI) is currently considered the most frequent cause of serious bacterial illness in children in the first 2 years of life. UTI in paediatrics can irreversibly damage the renal parenchyma and lead to chronic renal insufficiency and related problems. To avoid this risk, an early effective antibiotic treatment is essential. Moreover, prompt treatment is mandatory to improve the clinical condition of the patient, prevent bacteraemia, and avoid the risk of bacterial localization in other body sites. However, antibiotic resistance for UTI-related bacterial pathogens continuously increases, making recommendations rapidly outdated and the definition of the best empiric antibiotic therapy more difficult. Variation in pathogen susceptibility to antibiotics is essential for the choice of an effective therapy. Moreover, proper identification of cases at increased risk of difficult-to-treat UTIs can reduce the risk of ineffective therapy. In this review, the problem of emerging antibiotic resistance among pathogens associated with the development of paediatric febrile UTIs and the best potential solutions to ensure the most effective therapy are discussed. Literature analysis showed that the emergence of antibiotic resistance is an unavoidable phenomenon closely correlated with the use of antibiotics themselves. To limit the emergence of resistance, every effort to reduce and rationalise antibiotic consumption must be made. An increased use of antibiotic stewardship can be greatly effective in this regard.
2022
29
499
506
Antibiotic Resistance in Paediatric Febrile Urinary Tract Infections / Esposito, S.; Biasucci, G.; Pasini, A.; Predieri, B.; Vergine, G.; Crisafi, A.; Malaventura, C.; Casadio, L.; Sella, M.; Pierantoni, L.; Gatti, C.; Paglialonga, L.; Sodini, C.; La Scola, C.; Bernardi, L.; Autore, G.; Canto, G. D.; Argentiero, A.; Cantatore, S.; Ceccoli, M.; De Fanti, A.; Suppiej, A.; Lanari, M.; Principi, N.; Pession, A.; Iughetti, L.. - In: JOURNAL OF GLOBAL ANTIMICROBIAL RESISTANCE. - ISSN 2213-7173. - 29:(2022), pp. 499-506. [10.1016/j.jgar.2021.11.003]
Esposito, S.; Biasucci, G.; Pasini, A.; Predieri, B.; Vergine, G.; Crisafi, A.; Malaventura, C.; Casadio, L.; Sella, M.; Pierantoni, L.; Gatti, C.; Paglialonga, L.; Sodini, C.; La Scola, C.; Bernardi, L.; Autore, G.; Canto, G. D.; Argentiero, A.; Cantatore, S.; Ceccoli, M.; De Fanti, A.; Suppiej, A.; Lanari, M.; Principi, N.; Pession, A.; Iughetti, L.
File in questo prodotto:
File Dimensione Formato  
Esposito et al - 2021 J Glob Antimicrob Resist.pdf

Open access

Tipologia: Versione pubblicata dall'editore
Dimensione 372.57 kB
Formato Adobe PDF
372.57 kB Adobe PDF Visualizza/Apri
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/1268258
Citazioni
  • ???jsp.display-item.citation.pmc??? 3
  • Scopus 10
  • ???jsp.display-item.citation.isi??? 13
social impact